D. Bissett

2.7k total citations
54 papers, 2.1k citations indexed

About

D. Bissett is a scholar working on Oncology, Dermatology and Molecular Biology. According to data from OpenAlex, D. Bissett has authored 54 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 15 papers in Dermatology and 11 papers in Molecular Biology. Recurrent topics in D. Bissett's work include Cancer Treatment and Pharmacology (11 papers), Skin Protection and Aging (9 papers) and Amino Acid Enzymes and Metabolism (4 papers). D. Bissett is often cited by papers focused on Cancer Treatment and Pharmacology (11 papers), Skin Protection and Aging (9 papers) and Amino Acid Enzymes and Metabolism (4 papers). D. Bissett collaborates with scholars based in United Kingdom, United States and India. D. Bissett's co-authors include Daniel P. Hannon, R. K. Chatterjee, Kukizo Miyamoto, C Berge, Greg G. Hillebrand, Richard L. Anderson, Tomohiro Hakozaki, Raymond E. Boissy, Jinfu Zhuang and Atsushi Matsubara and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

D. Bissett

53 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Bissett United Kingdom 24 879 504 455 395 231 54 2.1k
Kyung Chan Park South Korea 25 678 0.8× 382 0.8× 812 1.8× 300 0.8× 138 0.6× 45 2.3k
Donald Bissett United States 22 799 0.9× 99 0.2× 349 0.8× 398 1.0× 125 0.5× 44 1.6k
Loren Pickart United States 23 202 0.2× 488 1.0× 602 1.3× 110 0.3× 129 0.6× 49 1.9k
Jürgen Fuchs Germany 22 605 0.7× 69 0.1× 705 1.5× 183 0.5× 255 1.1× 47 2.1k
John H. Epstein United States 34 1.6k 1.8× 269 0.5× 1.3k 2.9× 414 1.0× 504 2.2× 77 3.2k
S.L. Hsia United States 27 345 0.4× 534 1.1× 538 1.2× 213 0.5× 75 0.3× 104 2.2k
Rafał Czajkowski Poland 20 352 0.4× 216 0.4× 355 0.8× 274 0.7× 48 0.2× 128 1.5k
Vishal Madan United Kingdom 20 977 1.1× 509 1.0× 327 0.7× 118 0.3× 101 0.4× 68 2.1k
Lewis Tanenbaum United States 12 874 1.0× 161 0.3× 466 1.0× 164 0.4× 190 0.8× 18 2.1k
Apurva R. Patel United States 19 167 0.2× 258 0.5× 598 1.3× 71 0.2× 245 1.1× 34 1.7k

Countries citing papers authored by D. Bissett

Since Specialization
Citations

This map shows the geographic impact of D. Bissett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Bissett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Bissett more than expected).

Fields of papers citing papers by D. Bissett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Bissett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Bissett. The network helps show where D. Bissett may publish in the future.

Co-authorship network of co-authors of D. Bissett

This figure shows the co-authorship network connecting the top 25 collaborators of D. Bissett. A scholar is included among the top collaborators of D. Bissett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Bissett. D. Bissett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, H., D. Bissett, John F. Waterfall, et al.. (2007). First-into-man phase I and pharmacokinetic study of XR5944.14, a novel agent with a unique mechanism of action. British Journal of Cancer. 97(7). 844–850. 15 indexed citations
2.
Bissett, D., J Cassidy, Johann S. de Bono, et al.. (2004). Phase I and pharmacokinetic (PK) study of MAG-CPT (PNU 166148): a polymeric derivative of camptothecin (CPT). British Journal of Cancer. 91(1). 50–55. 92 indexed citations
3.
Bissett, D., et al.. (2004). Rhabdomyolysis in prostate cancer – caution in prescribing cyproterone acetate with statins. Clinical Oncology. 16(8). 528–529. 1 indexed citations
4.
Hakozaki, Tomohiro, Jinfu Zhuang, Atsushi Matsubara, et al.. (2002). The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. British Journal of Dermatology. 147(1). 20–31. 321 indexed citations
5.
Bissett, D., Howard L. McLeod, Mary Collier, et al.. (2001). Phase I dose-escalation and pharmacokinetic study of a novel folate analogue AG2034. British Journal of Cancer. 84(3). 308–312. 22 indexed citations
6.
Mackay, Helen, D. Bissett, Chris Twelves, & P. Vasey. (1999). A Pilot Study of Continuous Infusional 5-Fluorouracil, Doxorubicin and Cyclophosphamide in Breast Cancer. Clinical Oncology. 11(3). 174–178. 1 indexed citations
7.
Bissett, D., et al.. (1998). Angiosarcoma of the Penis. Urology. 51(1). 130–131. 13 indexed citations
8.
McClinton, Samuel, et al.. (1997). Lactate dehydrogenase as a tumour marker in adult Wilm’s tumour. British Journal of Urology. 80(4). 670–671. 5 indexed citations
9.
Bissett, D., et al.. (1996). Synergistic topical photoprotection by the iron chelator 2-furildioxime plus sunscreen. Journal of Investigative Dermatology. 106(4). 945. 1 indexed citations
10.
Bissett, D., S.B. Kaye, Grant Baxter, & J.G. Moss. (1996). Successful thrombolysis of SVC thrombosis associated with Hickman lines and continuous infusion chemotherapy. Clinical Oncology. 8(4). 247–249. 6 indexed citations
11.
Bissett, D., James Paul, Gordon Wishart, et al.. (1995). Epirubicin chemotherapy and advanced breast cancer after adjuvant CMF chemotherapy. Clinical Oncology. 7(1). 12–15. 3 indexed citations
12.
Wishart, Gordon, D. Bissett, James Paul, et al.. (1994). Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo-controlled randomized trial.. Journal of Clinical Oncology. 12(9). 1771–1777. 88 indexed citations
13.
Bissett, D., et al.. (1994). Gynaecological monitoring during tamoxifen therapy. The Lancet. 344(8932). 1244–1244. 43 indexed citations
14.
Bissett, D., et al.. (1994). The treatment of stage I carcinoma of the cervix in the west of Scotland 1980–1987. BJOG An International Journal of Obstetrics & Gynaecology. 101(7). 615–620. 4 indexed citations
15.
Bissett, D. & S.B. Kaye. (1993). Taxol and taxotere—Current status and future prospects. European Journal of Cancer. 29(9). 1228–1231. 23 indexed citations
16.
Bissett, D., et al.. (1991). The role of palliative radiotherapy in malignant mesothelioma. Clinical Oncology. 3(6). 315–317. 58 indexed citations
17.
Bissett, D., et al.. (1990). Long-term sequelae of treatment for testicular germ cell tumours. British Journal of Cancer. 62(4). 655–659. 57 indexed citations
18.
Bissett, D., et al.. (1989). Hyponatraemia Following Cisplatin Chemotherapy. Acta Oncologica. 28(6). 823–823. 7 indexed citations
19.
Berner, Bret, et al.. (1988). Preparation and characterization of a reconstituted stratum corneum film as a model membrane for skin transport. Archives of Dermatological Research. 280(4). 252–256. 10 indexed citations
20.
Bissett, D., et al.. (1987). Role of protein and calcium in stratum corneum cell cohesion. Archives of Dermatological Research. 279(3). 184–189. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyung Chan Park Breakdown of academic impact, for papers by Donald Bissett Breakdown of academic impact, for papers by Loren Pickart Breakdown of academic impact, for papers by Jürgen Fuchs Breakdown of academic impact, for papers by John H. Epstein Breakdown of academic impact, for papers by S.L. Hsia Breakdown of academic impact, for papers by Rafał Czajkowski Breakdown of academic impact, for papers by Vishal Madan Breakdown of academic impact, for papers by Lewis Tanenbaum Breakdown of academic impact, for papers by Apurva R. Patel
Rankless by CCL
2026